UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer

Breast cancer research : BCR, 2020-08, Vol.22 (1), p.89-89, Article 89

2020

Volltextzugriff (PDF)

Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation

Nature medicine, 2003-06, Vol.9 (6), p.796-800

2003

Volltextzugriff (PDF)

Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2

Clinical cancer research, 2009-08, Vol.15 (16), p.5032-5039

2009

Volltextzugriff (PDF)

Development of machine learning–powered models for prostate cancer HRD prediction

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.206-206

2023

Volltextzugriff (PDF)

Abstract 3825: Targeting activated PI3K/mTOR signaling overcomes resistance to CDK4/6-based therapies in preclinical ER+ breast cancer models

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3825-3825

2019

Volltextzugriff (PDF)

Pten Loss in Olig2 Expressing Neural Progenitor Cells and Oligodendrocytes Leads to Interneuron Dysplasia and Leukodystrophy

Stem cells (Dayton, Ohio), 2014-01, Vol.32 (1), p.313-326

2014

Volltextzugriff (PDF)

BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients with head and neck squamous cell carcinoma (HNSCC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.6045-6045

2016

Volltextzugriff (PDF)

Trial design of a first-in-human phase 1 evaluation of SY-1365, a first-in-class selective CDK7 inhibitor, with initial expansions in ovarian and breast cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS2600-TPS2600

2018

Volltextzugriff (PDF)

Abstract 4150: Anti-tumor activity of the PI3K/mTOR pathway inhibitors alpelisib (BYL719) and everolimus (RAD001) in xenograft models of acquired resistance to CDK-4/6 targeted therapy

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4150-4150

2017

Volltextzugriff (PDF)

Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor BKM120 in recurrent glioblastoma (GBM)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2015-2015

2013

Volltextzugriff (PDF)

Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor, N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain

The Journal of neuroscience, 1997-02, Vol.17 (4), p.1226-1242

1997

Volltextzugriff (PDF)

Brain cannabinoids in chocolate

Nature (London), 1996-08, Vol.382 (6593), p.677-678

1996

Volltextzugriff (PDF)

Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one

FEBS letters, 1997-02, Vol.403 (3), p.263-267

1997

Volltextzugriff (PDF)

Carbohydrate-deficient glycoprotein syndrome: normal glycosylation in the fetus

The Lancet (British edition), 1993-04, Vol.341 (8850), p.956-956

1993

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(8)
Animals
(7)
Life Sciences & Biomedicine
(7)
Humans
(5)
Cell Biology
(3)
Endocannabinoids
(3)
Oncology
(3)
Polyunsaturated Alkamides
(3)
Rats
(3)
Amidohydrolases - Antagonists & Inhibitors
(2)
Anandamide
(2)
Animal Biology
(2)
Antineoplastic Agents
(2)
Arachidonic Acids - Metabolism
(2)
Biochemistry & Molecular Biology
(2)
Cellular Biology
(2)
Female
(2)
Life Sciences
(2)
Mice
(2)
Pharmaceutical Sciences
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer

Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation

Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2

Development of machine learning–powered models for prostate cancer HRD prediction

Abstract 3825: Targeting activated PI3K/mTOR signaling overcomes resistance to CDK4/6-based therapies in preclinical ER+ breast cancer models

Pten Loss in Olig2 Expressing Neural Progenitor Cells and Oligodendrocytes Leads to Interneuron Dysplasia and Leukodystrophy

BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients with head and neck squamous cell carcinoma (HNSCC)

Trial design of a first-in-human phase 1 evaluation of SY-1365, a first-in-class selective CDK7 inhibitor, with initial expansions in ovarian and breast cancer

Abstract 4150: Anti-tumor activity of the PI3K/mTOR pathway inhibitors alpelisib (BYL719) and everolimus (RAD001) in xenograft models of acquired resistance to CDK-4/6 targeted therapy

Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor BKM120 in recurrent glioblastoma (GBM)

Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor, N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain

Brain cannabinoids in chocolate

Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one

Carbohydrate-deficient glycoprotein syndrome: normal glycosylation in the fetus

Suchergebnisse filtern